Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization

References

• CohenSYLarocheALeguenYSoubraneGCoscasGJEtiology of choroidal neovascularization in young patientsOphthalmology19961038124112448764794
   PubMed Web of Science ®Google Scholar
• VongphanitJMitchellPWangJJPrevalence and progression of myopic retinopathy in an older populationOphthalmology2002109470471111927427
   PubMed Web of Science ®Google Scholar
• LiuHHXuLWangYXWangSYouQSJonasJBPrevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye StudyOphthalmology201011791763176820447693
   PubMed Web of Science ®Google Scholar
• CurtinBJKarlinDBAxial length measurements and fundus changes of the myopic eye. I. The posterior fundusTrans Am Ophthalmol Soc1970683123345524211
   PubMedGoogle Scholar
• HayashiKOhno-MatsuiKShimadaNLong-term pattern of progression of myopic maculopathy: a natural history studyOphthalmology201011781595161120207005
   PubMed Web of Science ®Google Scholar
• WongTYOhno-MatsuiKLevezielNMyopic choroidal neovascularisation: current concepts and update on clinical managementBr J Ophthalmol201599328929624990871
   PubMed Web of Science ®Google Scholar
• WongTYFerreiraAHughesRCarterGMitchellPEpidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic reviewAm J Ophthalmol2014157192524099276
   PubMed Web of Science ®Google Scholar
• KobayashiKMandaiMSuzumaIKobayashiHOkinamiSExpression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyesRetina200222441842212172107
   PubMed Web of Science ®Google Scholar
• SekoYSekoYFujikuraHPangJTokoroTShimokawaHInduction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitroInvest Ophthalmol Vis Sci199940133287329110586955
   PubMed Web of Science ®Google Scholar
• Ohno-MatsuiKYoshidaTFutagamiSPatchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopiaBr J Ophthalmol200387557057312714395
   PubMed Web of Science ®Google Scholar
• WakabayashiTIkunoYChoroidal filling delay in choroidal neovascularisation due to pathological myopiaBr J Ophthalmol201094561161519846414
   PubMed Web of Science ®Google Scholar
• TanCSCheongKXLimLWLiKZTopographic variation of choroidal and retinal thicknesses at the macula in healthy adultsBr J Ophthalmol201498333934424288389
   PubMed Web of Science ®Google Scholar
• TanCSCheongKXMacular choroidal thicknesses in healthy adults – relationship with ocular and demographic factorsInvest Ophthalmol Vis Sci201455106452645825228543
   PubMed Web of Science ®Google Scholar
• IkunoYJoYHamasakiTTanoYOcular risk factors for choroidal neovascularization in pathologic myopiaInvest Ophthalmol Vis Sci20105173721372520207975
   PubMed Web of Science ®Google Scholar
• FujiwaraTImamuraYMargolisRSlakterJSSpaideRFEnhanced depth imaging optical coherence tomography of the choroid in highly myopic eyesAm J Ophthalmol2009148344545019541286
   PubMed Web of Science ®Google Scholar
• LevezielNYuYReynoldsRGenetic factors for choroidal neovascularization associated with high myopiaInvest Ophthalmol Vis Sci20125385004500922678500
   PubMed Web of Science ®Google Scholar
• Akagi-KurashigeYKumagaiKYamashiroKVascular endothelial growth factor gene polymorphisms and choroidal neovascularization in highly myopic eyesInvest Ophthalmol Vis Sci20125342349235322427559
   PubMed Web of Science ®Google Scholar
• AvilaMPWeiterJJJalkhAETrempeCLPruettRCSchepensCLNatural history of choroidal neovascularization in degenerative myopiaOphthalmology19849112157315816084222
   PubMed Web of Science ®Google Scholar
• NeelamKCheungCMOhno-MatsuiKLaiTYWongTYChoroidal neovascularization in pathological myopiaProg Retin Eye Res201231549552522569156
   PubMed Web of Science ®Google Scholar
• JonasJBJonasSBJonasRAParapapillary atrophy: histological gamma zone and delta zonePLoS One2012710e4723723094040
   PubMed Web of Science ®Google Scholar
• YoshidaTOhno-MatsuiKYasuzumiKMyopic choroidal neovascularization: a 10-year follow-upOphthalmology200311071297130512867382
   PubMed Web of Science ®Google Scholar
• ChanWMOhjiMLaiTYLiuDTTanoYLamDSChoroidal neovascularisation in pathological myopia: an update in managementBr J Ophthalmol200589111522152816234465
   PubMed Web of Science ®Google Scholar
• SilvaRMyopic maculopathy: a reviewOphthalmologica2012228419721322846778
   PubMed Web of Science ®Google Scholar
• TanCSNgoWKCheongKXComparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyesBr J Ophthalmol201599335435825273828
   PubMed Web of Science ®Google Scholar
• SoubraneGChoroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatmentSurv Ophthalmol200853212113818348878
   PubMed Web of Science ®Google Scholar
• Ruiz-OlivaFCortésJVerteporfin in photodynamic therapy (VIP) study groupOphthalmology200210961043 author reply 1043–104412045040
   PubMed Web of Science ®Google Scholar
• KeanePALiakopoulosSChangKTComparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysisBr J Ophthalmol20089281081108518586903
   PubMed Web of Science ®Google Scholar
• SawaMGomiFTsujikawaMAbnormal fundus autofluorescence patterns in myopic choroidal neovascularisationBr J Ophthalmol20089291236124018617541
   PubMed Web of Science ®Google Scholar
• TanCSLimLWChowVSOptical coherence tomography angiography evaluation of the parafoveal vasculature and its relationship with ocular factorsInvest Ophthalmol Vis Sci2016579224234
   Web of Science ®Google Scholar
• TanCSHariprasadSMLimLWSaddaSREvaluation of the retinal and choroidal vasculature with OCT angiography versus conventional angiographyOphthalmic Surg Lasers Imaging Retina201647121081108527977830
   PubMed Web of Science ®Google Scholar
• JungJJChenMHChungPYLeeSSSwept-source optical coherence tomography angiography for choroidal neovascularization after bevacizumab and photodynamic therapyAm J Ophthalmol2016114
   Google Scholar
• QuerquesLGiuffrèCCorviFOptical coherence tomography angiography of myopic choroidal neovascularisationBr J Ophthalmol2017101560961527531357
   PubMed Web of Science ®Google Scholar
• QuerquesGCorviFQuerquesLSouiedEHBandelloFOptical coherence tomography angiography of choroidal neovascularization secondary to pathologic myopiaDev Ophthalmol20165610110627023343
   PubMedGoogle Scholar
• MiyataMOotoSHataMDetection of myopic choroidal neovascularization using optical coherence tomography angiographyAm J Ophthalmol201616510811426973049
   PubMed Web of Science ®Google Scholar
• LiuBBaoLZhangJOptical coherence tomography angiography of pathological myopia sourced and idiopathic choroidal neovascularization with follow-upMedicine (Baltimore)20169514e326427057880
   PubMed Web of Science ®Google Scholar
• HayashiKOhno-MatsuiKShimadaNLong-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopiaAm J Ophthalmol2011151113714720970774
   PubMed Web of Science ®Google Scholar
• GiansantiFVirgiliGDonatiMCLong-term results of photodynamic therapy for subfoveal choroidal neovascularization with pathologic myopiaRetina20123281547155222481476
   PubMed Web of Science ®Google Scholar
• Ruiz-MorenoJMMonteroJALong-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyesEur J Ophthalmol200212211712212022283
   PubMed Web of Science ®Google Scholar
• TanoYPathologic myopia: where are we now?Am J Ophthalmol2002134564566012429239
   PubMed Web of Science ®Google Scholar
• VirgiliGMenchiniFLaser photocoagulation for choroidal neovascularisation in pathologic myopiaCochrane Database Syst Rev20054CD004765
   Google Scholar
• ParodiMBIaconoPPapayannisAShethSBandelloFLaser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopiaArch Ophthalmol2010128443744220142520
   PubMedGoogle Scholar
• Schmidt-ErfurthULaquaHSchlotzer-SchrehardUViestenzANaumannGOHistopathological changes following photodynamic therapy in human eyesArch Ophthalmol2002120683584412049594
   PubMedGoogle Scholar
• HusainDMillerJWMichaudNConnollyEFlotteTJGragoudasESIntravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularizationArch Ophthalmol199611489789858694734
   PubMedGoogle Scholar
• BlinderKJBlumenkranzMSBresslerNMVerteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial – VIP report no. 3Ophthalmology2003110466767312689884
   PubMed Web of Science ®Google Scholar
• Verteporfin in Photodynamic Therapy Study GroupPhotodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial – VIP report no. 1Ophthalmology2001108584185211320011
   PubMed Web of Science ®Google Scholar
• SchnurrbuschUEJochmannCWiedemannPWolfSQuantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopiaGraefes Arch Clin Exp Ophthalmol2005243882983316133036
   PubMed Web of Science ®Google Scholar
• TanCSChewMCLimTHComparison of foveal-sparing with fovealinvolving photodynamic therapy for myopic choroidal neovascularizationEye (Lond)2014281172224051405
   PubMed Web of Science ®Google Scholar
• WolfSBalciunieneVJLaganovskaGRADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopiaOphthalmology2014121368269224326106
   PubMed Web of Science ®Google Scholar
• TufailANarendranNPatelPJRanibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR studyOphthalmology201312091944194524001532
   PubMed Web of Science ®Google Scholar
• FranqueiraNCachuloMLPiresILong-term follow-up of myopic choroidal neovascularization treated with ranibizumabOphthalmologica20122271394422056757
   PubMed Web of Science ®Google Scholar
• MonésJMAmselemLSerranoAGarciaMHijanoMIntravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month resultsEye (Lond)20092361275128019478826
   PubMed Web of Science ®Google Scholar
• SilvaRMRuiz-MorenoJMRosaPIntravitreal ranibizumab for myopic choroidal neovascularization: 12-month resultsRetina201030340741220094007
   PubMed Web of Science ®Google Scholar
• LaiTYChanWMLiuDTLamDSIntravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopiaRetina200929675075619357555
   PubMed Web of Science ®Google Scholar
• KungYHWuTTHuangYHOne-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularizationActa Ophthalmol2014928e615e62024924911
   PubMed Web of Science ®Google Scholar
• IkunoYOhno-MatsuiKWongTYMYRROR InvestigatorsIntravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR StudyOphthalmology201512261220122725745875
   PubMed Web of Science ®Google Scholar